US District Court Returns Binding Verdict of Invalidity of Two Claims of Covidien Patent Covering Trocar Seal Technology

Applied Medical to Pursue Post-Trial Motions to Overturn Covidien Infringement Verdict

ORANGE COUNTY, California, March 23, 2010 - Applied Medical announced today that a United States District Court jury
for the Eastern District of Texas returned a binding verdict of invalidity of
two claims of a Covidien patent covering trocar seal technology.

Applied Medical also noted that the jury found Claim 6 of U.S. Patent No.
5,895,377 to be infringed by Applied Medical's older generation Kii(TM) and
Universal(R) access systems. Applied Medical has progressed to a newer
generation of Kii and Universal access systems. Moreover, Applied Medical
believes the jury findings of infringement of the prior generation devices
are contrary to the facts presented at trial. Applied Medical will continue
to pursue post-trial motions seeking to overturn the infringement verdict.

"While we are pleased with the invalidity findings, we are disappointed
that the jury returned an infringement verdict of '377 patent despite the
evidence presented at trial. We maintain an unyielding belief that we have
not infringed any valid U.S. patents," said Applied Medical's Surgical Group
President, Gary Johnson.

About Applied Medical

Applied Medical is a new generation medical device company committed to
the pursuit of sustainable, progressive health care solutions. Applied
designs, manufactures and distributes innovative surgical products that
enable enhanced patient outcomes while providing cost effective procedures
and techniques. For more information, visit www.appliedmedical.com.

Mary Jo Stegwell, Senior Vice President, Corporate Communications, Applied Medical, +1-949-713-8000